Fact CheckerSign in

NCT07175324Not yet recruiting

Oct-A and Perimetry in Multiple Sclerosis

Correlation Between Optical Coherence Tomography Angiography and Visual Field Changes in Patients With Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 16 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to assess retinal vascular density using OCT-A and correlate these parameters with visual field changes in MS patients with and without a history of ON

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
32 (estimated)
First submitted
3 Sept 2025
Start date
Sept 2025
Primary completion date
Sept 2026
Lead sponsor
Assiut University
NCT number
NCT07175324

What you commit to

  • Study type: Observational
  • Planned participants: 32
  • From Sept 2025 to the primary completion date, Sept 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • .History of ocular diseases unrelated to MS that could confound OCTA or visual field results.
  • .Media opacities preventing quality OCTA imaging. .Systemic diseases that may affect retinal vasculature (e.g., uncontrolled hypertension, diabetes).

Other

  • .Recent optic neuritis episode within a defined period (often 3-6 months) to avoid acute inflammation effects.
  • .Poor cooperation or inability to complete visual field testing reliably

Who the study is looking for

  • Diagnosis of relapsing-remitting multiple sclerosis (RR-MS) or other MS subtypes confirmed by established neurological criteria. .Ability to undergo OCTA imaging and visual field testing. .Visual acuity sufficient to perform reliable visual field testing.
  • Absence of other ocular diseases affecting the retina or optic nerve (e.g., diabetic retinopathy, glaucoma)

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.